About usSign in

Autism Impact Fund

WebsiteLinkedInTwittercbCrunchbase
Status
ACTIVE
Global HQ
San Francisco, United States
Countries of investment
  • USA Silicon Valley
  • China
Investment stages
  • Pre-Seed
  • Seed
  • Series A
  • Series B
  • Series C
Industries
  • Manufacturing
  • Consumer Health
  • Retail
  • Media/Content
  • Pharmaceuticals
  • Real Estate/Proptech
About
AIF supports innovative solutions across the ASD continuum, investing in companies that address unmet needs in diagnosis, treatment, and support for individuals with ASD.
Min check size
$100K
Max check size
$5M
Fund size
NPS

Investment Thesis

The Autism Impact Fund aims to revolutionize the diagnosis, treatment, and living with autism spectrum disorder (ASD) and related conditions through venture capital investments. They focus on accelerating the development and delivery of emerging technologies, translational science, and innovative services.
Lead investor
Co Invest
Number of exits
Preferred contact method

Team

Christopher Male – Founder and Managing Partner

Jared Ramagli – Partner

Samantha Joseph – Principal

Portfolio

Auticon

Axial Therapeutics

BioROSA Technologies

Cortica

Floreo

Healios

Joshin

Juniper

Mara BioSystems

SpectrumAi

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp